CUAMC
RANI icon

China Universal Asset Management Company’s Rani Therapeutics RANI Stock Holding History

China Universal Asset Management Company’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6K Buy
17,887
+576
+3% +$511 ﹤0.01% 501
2026
Q1 		$12.7K Buy
17,311
+1,417
+9% +$1.81K ﹤0.01% 499
2025
Q4 		$21.5K Buy
+15,894
New +$24K ﹤0.01% 486
2022
Q4 		– Sell
-229
Closed -$2K – 448
2022
Q3 		$2K Buy
+229
New +$2.43K ﹤0.01% 355

Other funds holding RANI

KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
WDL
Well Done LLC Holland, Michigan $743M AUM 22.58% 1-Year Est. Return
M
MOTCO San Antonio, Texas $1.17B AUM 23.84% 1-Year Est. Return
TIA
Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
CSP
Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return

China Universal Asset Management Company's RANI Position: Q2 2026 in Review

China Universal Asset Management Company increased its Rani Therapeutics (RANI) stake by 3.3% in Q2 2026, buying an estimated $511 and bringing the position to 17,887 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #501.

China Universal Asset Management Company first reported a position in RANI in Q3 2022 and has held it in 4 quarters since. The position peaked at $21.5K in Q4 2025. 13 funds tracked by Wall St. Rank hold RANI as of Q2 2026.

  • China Universal Asset Management Company held 17,887 shares of Rani Therapeutics worth $13.6K as of Q2 2026.
  • China Universal Asset Management Company bought 576 Rani Therapeutics shares in Q2 2026, an estimated $511.
  • Rani Therapeutics made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #501 holding.
  • China Universal Asset Management Company first reported a position in Rani Therapeutics in Q3 2022 and has held it in 4 quarters since.
  • China Universal Asset Management Company's Rani Therapeutics position peaked at $21.5K in Q4 2025.
  • 13 funds tracked by Wall St. Rank held Rani Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.